Literature DB >> 12543902

Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure.

Joëlle L Nortier1, Heinz H Schmeiser, Marie-Carmen Muniz Martinez, Volker M Arlt, Catherine Vervaet, Christian H Garbar, Philippe Daelemans, Jean-Louis Vanherweghem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12543902     DOI： 10.1093/ndt/18.2.426

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  13 in total

Review 1.  Herbal therapy use by cancer patients: a literature review on case reports.

Authors:  Oluwadamilola Olaku; Jeffrey D White
Journal:  Eur J Cancer       Date:  2010-12-23       Impact factor: 9.162

Review 2.  Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

3.  Mutagenicity and DNA adduct formation by aristolochic acid in the spleen of Big Blue® rats.

Authors:  L Patrice McDaniel; Elizabeth R Elander; Xiaoqing Guo; Tao Chen; Volker M Arlt; Nan Mei
Journal:  Environ Mol Mutagen       Date:  2012-04-17       Impact factor: 3.216

4.  DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver.

Authors:  Nan Mei; Volker M Arlt; David H Phillips; Robert H Heflich; Tao Chen
Journal:  Mutat Res       Date:  2006-09-28       Impact factor: 2.433

5.  Preventing aristolochic acid nephropathy.

Authors:  Nelomi Anandagoda; Graham M Lord
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-13       Impact factor: 8.237

6.  Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers.

Authors:  Marie Stiborová; Jiří Hudeček; Eva Frei; Heinz H Schmeiser
Journal:  Interdiscip Toxicol       Date:  2008-06

Review 7.  Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition.

Authors:  Thomas Baudoux; Inès Jadot; Anne-Emilie Declèves; Marie-Hélène Antoine; Jean-Marie Colet; Olivia Botton; Eric De Prez; Agnieszka Pozdzik; Cécile Husson; Nathalie Caron; Joëlle L Nortier
Journal:  Front Med (Lausanne)       Date:  2022-05-04

Review 8.  Balkan endemic nephropathy-current status and future perspectives.

Authors:  Nikola M Pavlović
Journal:  Clin Kidney J       Date:  2013-06

Review 9.  Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.

Authors:  Hsiao-Yu Yang; Pau-Chung Chen; Jung-Der Wang
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

Review 10.  An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.

Authors:  Inès Jadot; Anne-Emilie Declèves; Joëlle Nortier; Nathalie Caron
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.